EPGL Medical Unveils New Devices and Intellectual Property Under EP Global Communications, Inc. Ownership
June 18 2013 - 11:59AM
IRVINE, Jun 18, 2013 (GLOBE NEWSWIRE via COMTEX) - via PRWEB - EP
Global Communications, Inc. (the Company), (Stock Ticker: EPGL)
EPGL Medical Sciences, is pleased to announce several new devices
resulting from the TopSpin technology recently announced. Many of
these devices have not been revealed before today. To Compliment
the MPDD, the new MPTT will be first to become a prototype this
fall and new FDA 510k and PMA Applications are being prepared for
filing during 3rd and 4th Quarters. EPGL has filed patents and owns
unique Intellectual Property for each of the following new smart
medical devices: 1. A new advanced ablation device for nerve pain
treatment in the back. 2. A new advanced ablation device for nerve
treatment of Facial Glabballar Frowning. 3. A new advanced device
for elimination of facial wrinkles. 4. A new advanced Epidural
device. 5. A new advanced power source for TopSpin medical devices.
6. A new and promising device for treatment of Retinitis Pigmentosa
7. A new and promising device for treatment of Macular Degeneration
8. A new and promising treatment for Hearing Loss 9. A new more
accurate treatment for trigger points in the muscles (MPTT) 10. A
new advanced device for treatment of prostate tumors. 11. A new
advanced endoscopic device. 12. A new advanced device for delivery
of micron sized drug payloads. 13. A new advanced device for
delivery of micro mechanical devices into the body. 14. A new
advanced device for biopsy. 15. A new advanced device for stem cell
treatment delivery. 16. A new advanced contact lens device. Several
more devices beyond this list will be revealed in coming months by
the Company. This represents the beginning for EPGL technological
development. About EP Global Communications, Inc. / EPGL Medical EP
Global Communications, Inc. is a medical device manufacturer and
marketing company with exclusive rights to a new FDA 510k cleared
medical device called the Muscle Pain Detection Device. The MPDD is
a revolutionary new diagnostic tool for the detection of muscular
originated pain in the human body. Safe Harbor Statement Certain
matters discussed in this press release are "forward-looking
statements" intended to qualify for the safe harbors from liability
established by the Private Securities Litigation Reform Act of
1995. In particular, the Company's statements regarding trends in
the marketplace and potential future results are examples of such
forward-looking statements. The forward-looking statements include
risks and uncertainties, including, but not limited to, the timing
of projects due to the variability in size, scope and duration of
projects, estimates made by management with respect to the
Company's critical accounting policies, regulatory delays, clinical
study results which lead to reductions or cancellations of
projects, and other factors, including general economic conditions
and regulatory developments, not within the Company's control. The
factors discussed herein and expressed from time to time in the
Company's filings with the Securities and Exchange Commission could
cause actual results and developments to be materially different
from those expressed in or implied by such statements. The
forward-looking statements are made only as of the date of this
press release and the Company undertakes no obligation to publicly
update such forward-looking statements to reflect subsequent events
or circumstances. This article was originally distributed on PRWeb.
For the original version including any supplementary images or
video, visit http://www.prweb.com/releases/2013/6/prweb10843557.htm
CONTACT: EP Global Communications, Inc. Brady Peterson
investors@epglmed.com 877-287-6175 (C) Copyright 2013
GlobeNewswire, Inc. All rights reserved.